Zimmer Biomet: Adding To The Growth Profile
Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 drug overhang. Explore more details here.
Zimmer Biomet forecasts 2025 profit below estimates
Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it anticipates a hit from a strong dollar. The company expects 2025 adjusted profit to be in the range of $8.
Zimmer Biomet looks to grow ASC market with newest buy
Through the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment to outpace hips and knees, moving forward, according to a Feb. 6 report from Medtech Dive. Zimmer Biomet also expects that the acquisition will give the company a larger presence in the ASC space.
Zimmer Biomet beats The Street in Q4
Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus forecast.
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2024 Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, February 06,
Zimmer Biomet Holdings Inc. Q4 Profit Decreases, But Beats Estimates
Zimmer Biomet Holdings Inc. (ZBH) announced a profit for fourth quarter that decreased from the same period last year but beat the
Why Is Zimmer Biomet Stock Trading Lower On Thursday?
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported fourth-quarter adjusted EPS of $2.31, up from $2.20 a year ago, beating the Street estimates of $2.30. The orthopedic giant reported sales of $2.02 billion,
Zimmer Biomet (ZBH) Surpasses Q4 Earnings and Revenue Estimates
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.31 per share, beating the Zacks Consensus Estimate of $2.30 per share. This compares to earnings of $2.20 per share a year ago. These figures are adjusted for non-recurring items.
Zimmer Biomet Holdings Full Year 2024 Earnings: EPS Misses Expectations
Full Year 2024 Results Key Financial Results Revenue: US$7.68b (up 3.8% from ...
Zimmer Biomet price target lowered to $125 from $130 at RBC Capital
RBC Capital analyst Shagun Singh lowered the firm’s price target on Zimmer Biomet (ZBH) to $125 from $130 but keeps an Outperform rating on the ...
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...
Zimmer Biomet Holdings Inc (ZBH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Zimmer Biomet Holdings Inc (ZBH) reports robust Q4 performance with nearly 5% constant currency revenue growth and outlines ...
Zimmer Biomet price target lowered to $119 from $126 at Raymond James
Raymond James lowered the firm’s price target on Zimmer Biomet (ZBH) to $119 from $126 and keeps an Outperform rating on the shares. Zimmer ...
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors
Shares of Zimmer Biomet Holdings Inc. ZBH slipped 5.14% to $102.69 Thursday, on what proved to be an all-around mixed trading ...
MassDevice8d
Zimmer Biomet to buy Paragon 28 for $1.2B
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
Analysts Are Bullish on Top Healthcare Stocks: Globus Medical (GMED), Zimmer Biomet Holdings (ZBH)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...